TG Therapeutics stock forecast
TG Therapeutics (NKB2) Stock Forecast & Price Target
NKB2 Analyst Ratings
NKB2 Stock 12 Month Forecast
Average Price Target
CHF64.23▲(0.00% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Michael DiFiore | Evercore ISI | CHF61.37→CHF59.69 | buy | ― | Reiterated | 11/10/26 | ||
| Alec Stranahan | Bank of America Securities | ― | sell | ― | Reiterated | 11/10/26 | ||
| Tara Bancroft | TD Cowen | CHF63.06 | buy | ― | Reiterated | 11/09/26 | ||
| Brian Cheng | J.P. Morgan | CHF60.53 | buy | ― | Reiterated | 11/09/26 | ||
| Emily Bodnar | H.C. Wainwright | CHF65.58 | buy | ― | Reiterated | 09/21/26 | ||
| William Wood | B. Riley Securities | CHF72.30 | buy | ― | Reiterated | 09/02/26 | ||
| Roger Song | Jefferies | CHF69.78 | buy | ― | Reiterated | 07/14/26 | ||
| Corinne Johnson | Goldman Sachs | CHF34.47 | hold | ― | Reiterated | 06/03/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Michael DiFioreEvercore ISI | BuyReiteratedCHF61.37→CHF59.69 | 11/10/26 | ― | ||
| Alec StranahanBank of America Securities | SellReiterated | 11/10/26 | ― | ||
| Tara BancroftTD Cowen | BuyReiteratedCHF63.06 | 11/09/26 | ― | ||
| Brian ChengJ.P. Morgan | BuyReiteratedCHF60.53 | 11/09/26 | ― | ||
| Emily BodnarH.C. Wainwright | BuyReiteratedCHF65.58 | 09/21/26 | ― | ||
| William WoodB. Riley Securities | BuyReiteratedCHF72.30 | 09/02/26 | ― | ||
| Roger SongJefferies | BuyReiteratedCHF69.78 | 07/14/26 | ― | ||
| Corinne JohnsonGoldman Sachs | HoldReiteratedCHF34.47 | 06/03/26 | ― |
Best Analysts Covering TG Therapeutics
Copying Emily Bodnar's trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +16.99% per trade.
Copying Emily Bodnar's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +61.85% per trade.
Copying Emily Bodnar's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +65.00% per trade.
NKB2 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 5 | 3 | 1 |
| Buy | 7 | 6 | 7 | 4 | 6 |
| Hold | 3 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 2 | 3 | 2 | 1 | 0 |
| total | 19 | 17 | 14 | 8 | 8 |
In the current month, NKB2 has received 7 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. NKB2 average Analyst price target in the past 3 months is 64.23.
NKB2 Financial Forecast
NKB2 Earnings Forecast
Next quarter’s earnings estimate for NKB2 is CHF 0.43 with a range of CHF 0.21 to CHF 0.53. The previous quarter’s EPS was CHF 0.29. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
NKB2 Sales Forecast
Next quarter’s sales forecast for NKB2 is CHF 239.55M with a range of CHF 220.31M to CHF 247.63M. The previous quarter’s sales results were CHF 214.56M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

